46.46.Z - Wholesale of pharmaceutical goods
10.86.Z - Manufacture of homogenised food preparations and dietetic food
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
62 - Computer programming, consultancy and related activities
63.12.Z - Web portals
72.1 - Research and experimental development on natural sciences and engineering
73.20.Z - Market research and public opinion polling
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Total assets | 163,3 | 326,2 | 647,7 | 98,6 |
Total operating revenue | 163,4 | 194,9 | 189 | -3 |
Gross profit / loss | 116,4 | 17,4 | 0,7 | -96,2 |
Liabilities and provisions | 47,4 | 195,2 | 597,9 | 206,3 |
Equity | 115,9 | 131 | 49,8 | -62 |
Net profit / loss | 105,9 | 15,1 | -0,4 | -102,5 |
Current assets | 163,3 | 284,5 | 626 | 120 |
% | % | % | p.p. | |
Return on equity (ROE) | 91,4 | 11,5 | -0,8 | -12,3 |
Return on sales (ROS) | 64,8 | 7,7 | -0,2 | -7,9 |
Gross profit margin | 71,2 | 8,9 | 0,4 | -8,5 |
Equity ratio | 71 | 40,2 | 7,7 | -32,5 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.